Hikma Pharmaceuticals PLC (LON:HIK)

Hikma Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 14, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,962	4,419	3,955	3,418	5,136	5,803
Market Cap Growth	4.44%	11.74%	15.72%	-33.45%	-11.50%	20.30%
Enterprise Value	4,936	5,234	4,766	4,383	5,569	6,208
Last Close Price	17.89	19.58	17.03	14.38	20.08	22.42
PE Ratio	14.69	15.41	26.52	21.91	16.52	18.38
Forward PE	10.12	10.90	10.80	9.65	14.20	18.48
PS Ratio	1.69	1.77	1.75	1.64	2.72	3.38
PB Ratio	2.13	2.38	2.28	1.92	2.82	3.69
P/TBV Ratio	4.11	4.79	4.59	4.07	4.46	6.29
P/FCF Ratio	14.95	13.87	11.48	10.51	14.11	27.13
P/OCF Ratio	10.30	9.81	8.29	7.77	10.90	17.08
PEG Ratio	1.19	1.66	1.55	2.10	1.49	2.02
EV/Sales Ratio	2.10	2.10	2.11	2.10	2.95	3.62
EV/EBITDA Ratio	8.74	8.33	7.62	7.88	10.50	12.96
EV/EBIT Ratio	11.66	10.78	9.71	10.61	13.44	15.70
EV/FCF Ratio	18.63	16.42	13.83	13.47	15.30	29.03
Debt / Equity Ratio	0.61	0.56	0.54	0.60	0.34	0.43
Debt / EBITDA Ratio	2.01	1.64	1.46	1.88	1.16	1.40
Debt / FCF Ratio	4.29	3.27	2.71	3.27	1.72	3.19
Asset Turnover	0.62	0.64	0.63	0.57	0.60	0.58
Inventory Turnover	1.82	1.82	1.76	1.70	1.73	1.70
Quick Ratio	0.65	0.60	0.82	1.05	1.31	1.05
Current Ratio	1.24	1.14	1.57	1.86	2.06	1.87
Return on Equity (ROE)	15.38%	15.98%	8.81%	8.28%	18.20%	20.11%
Return on Assets (ROA)	6.97%	7.75%	8.54%	7.04%	8.24%	8.37%
Return on Capital (ROIC)	9.43%	10.81%	11.44%	9.23%	10.97%	11.45%
Return on Capital Employed (ROCE)	16.60%	19.30%	18.70%	14.70%	16.70%	17.40%
Earnings Yield	6.84%	6.49%	3.77%	4.57%	6.05%	5.44%
FCF Yield	6.69%	7.21%	8.71%	9.52%	7.09%	3.69%
Dividend Yield	3.26%	3.26%	3.32%	3.23%	1.99%	1.63%
Payout Ratio	47.71%	48.75%	72.10%	66.49%	28.50%	25.29%
Buyback Yield / Dilution	0.18%	-0.51%	1.13%	3.47%	2.10%	2.06%
Total Shareholder Return	3.50%	2.76%	4.45%	6.70%	4.09%	3.69%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.